Purine nucleoside analogues for treating flaviviridae including hepatitis C
US8742101B2 · kind B2 · utility
23Cited by
47References
38Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 13, 2008 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Apr 10, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/23
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.